EP 1368473 A2 20031210 - NEUROTRANSMISSION-ASSOCIATED PROTEINS
Title (en)
NEUROTRANSMISSION-ASSOCIATED PROTEINS
Title (de)
NEUROTRANSMISSION-ASSOZIIERTE PROTEINE
Title (fr)
PROTEINES ASSOCIEES A LA NEUROTRANSMISSION
Publication
Application
Priority
- US 0204536 W 20020215
- US 26974801 P 20010216
- US 29052401 P 20010511
- US 34374201 P 20011019
Abstract (en)
[origin: WO02066646A2] The invention provides human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NTRAN.
IPC 1-7
C12N 15/12; C07K 14/705; C07K 16/28; A01K 67/027; C12Q 1/68; G01N 33/577; G01N 33/68; A61K 38/17; A61K 39/395; A61P 25/00
IPC 8 full level
G01N 33/53 (2006.01); A61K 31/7088 (2006.01); A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/04 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); A61P 5/00 (2006.01); A61P 5/14 (2006.01); A61P 7/00 (2006.01); A61P 7/06 (2006.01); A61P 7/08 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/00 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 33/00 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C07K 16/46 (2006.01); C07K 19/00 (2006.01); C12M 1/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/58 (2006.01); G01N 37/00 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 3/00 (2017.12); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 5/14 (2017.12); A61P 7/00 (2017.12); A61P 7/06 (2017.12); A61P 7/08 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/00 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/20 (2017.12); A61P 25/22 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 33/00 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); C07K 14/705 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01)
Citation (search report)
See references of WO 02066646A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02066646 A2 20020829; WO 02066646 A3 20030918; CA 2438235 A1 20020829; EP 1368473 A2 20031210; JP 2004523236 A 20040805
DOCDB simple family (application)
US 0204536 W 20020215; CA 2438235 A 20020215; EP 02718986 A 20020215; JP 2002566351 A 20020215